Company Summary
RAM RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITED
Services/Health Care Services
SET
CG Report:   -
 
  Data as of 28 Jan 2022  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
35.00 40.00 / 27.10 15.39 2.73 120.00 42,000.00 60,529.10 4,654.03 11.60
News
Date/Time Subject
28 Jan 2022 12:33   The interim dividend payment
10 Jan 2022 17:03   Announcement about the resignation of Company's Director and an Independent Director
27 Dec 2021 17:04   Abandon the right of Vibharam to buy new shares of Seriruk Co.,Ltd.
15 Nov 2021 18:21   Financial Statement Quarter 3/2021 (Reviewed)
15 Nov 2021 18:21   Financial Performance Quarter 3 (F45) (Reviewed)
more

Company Profile
Address 2138 RAMKHAMHAENG ROAD, HUAMARK, BANG KAPI Bangkok 10240
Telephone 0-2374-0197-216, 0-2374-0798-807, 0-2732-0476-487
Fax 0-2374-0804
URL www.ram-hosp.co.th
Establish Date 17/11/1976 Listed Date 13/09/1991
IPO Price (Baht) 68.00 @Par10.00 Baht
IPO Financial Advisory
  • PHATRA THANAKIT PUBLIC COMPANY LIMITED
  • Par 0.10 Baht
    Last Par Change Old 0.50 : New 0.10 @ 09/11/2021

    Business
    The Company is a private hospital named as RamkhamhaengHospital including 7 sister hospital networks.RAM has the resources,experience and expertise to provide international quality health care service .

    Free Float 31 Mar 2021 30 Mar 2020
    % /Shareholders
    19.88% 824 25.76% 791
    Foreign Shareholders 20.29% (As of 28/01/2022) Foreign Limit 35.00%
    NVDR Shareholders  0.24% (As of 28/01/2022)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
    5 Days -1.41 -2.36 -0.61
    20 Days -10.83 -8.07 -10.72
    60 Days 6.06 9.83 5.08
    120 Days 27.27 25.66 19.36
    YTD -11.95 -9.28 -10.98
    P/E (X) 15.39 30.06 20.59
    P/BV (X) 2.73 4.15 1.77
    Turnover Ratio (%) 0.03 0.13 1.16

    Top 10 Major Shareholders(@12 Nov 2021) Share %
    1. บริษัท เอฟแอนด์เอส 79 จำกัด 280,460,475 23.37
    2. CYPRESS CONSOLIDATED HEALTHCARE PTE.LTD. . 240,000,000 20.00
    3. บริษัท โรงพยาบาลเชียงใหม่ราม จำกัด 86,230,000 7.19
    4. บริษัท โรงพยาบาลวิภาวดี จำกัด (มหาชน) 74,568,680 6.21
    5. บริษัท สินแพทย์ จำกัด 40,551,500 3.38
    6. MR. PITCHAYA SOMBURANASIN 34,166,100 2.85
    7. นาย ศิริพงศ์ เหลืองวารินกุล 29,508,200 2.46
    8. MR. TALIT CHUEN-IM 22,536,200 1.88
    9. น.ส. RUKKAGEE KANJANAPITAK 21,068,600 1.76
    10. นาย ฤชิษฐ์ กาญจนพิทักษ์ 17,971,000 1.50

    Management Position
    1. Mr. AURCHAT KANJANAPITAK CHAIRMAN / PRESIDENT OF EXECUTIVE COMMITTEE
    2. Mr. CHAMNAN CHANAPAI MANAGING DIRECTOR / DIRECTOR
    3. Mr. VIRAT CHUEN-IM DIRECTOR / DIRECTOR
    4. Mr. SIRIPONG LUENGVARINKUL DIRECTOR
    5. Mr. SUTHEE LEELASETAKUL DIRECTOR
    6. Mr. JERMPOL BHUMITRAKUL DIRECTOR
    7. Miss TASSAWAN SIRIVONGS DIRECTOR
    8. Mr. YOUNG-TAEG PARK DIRECTOR
    9. Mr. BENNY LIM DIRECTOR
    10. Mr. ERIC MARNANDUS DIRECTOR
    11. Dr. PITCHAYA SOMBURANASIN DIRECTOR
    12. Mr. KAJIT HABANANAANDA INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    13. Mr. PINIT HIRUNYACHOTE INDEPENDENT DIRECTOR
    14. Mr. PRAMOL APIRAT INDEPENDENT DIRECTOR / CHAIRMAN OF AUDIT COMMITTEE
    15. Miss KITTIYARAT JIROJDAMRONGCHAI INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    28 Jan 2022
    2021
    30 Dec 2021
    2020
    30 Dec 2020
    Listed share (M.) 1,200.00  1,200.00  240.00 
    Market Cap (MB.) 42,000.00  47,700.00  33,480.00 
    Price (B./share) 35.00  39.75  27.90 
    BVPS (B./Share) 12.84  12.84  44.01 
    P/BV (X) 2.73  3.10  3.17 
    P/E (X) 15.39  17.48  68.66 
    Turnover Ratio (%) 0.67  9.80  0.81 
    Value Trade/Day (MB.) 15.47  13.17  1.12 
    Beta 0.40  0.39  0.13 
     
    Rate of Return YTD  2021  2020 
    Price Change (%) -11.95  42.47  -8.22 
    Dividend Yield (%) 2.06  1.81  2.58 
    Payout Ratio 0.32  0.32  1.77 
    Dividend Policy Not less than 20% of net profit (base on the separated financial statements) after deducting corporate income tax and legal reserve

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    - 0.18 Baht 26 Nov 2021 Cash
    - 0.90 Baht 27 Aug 2021 Cash
    01 Jan 2020 - 31 Dec 2020 0.90 Baht 28 May 2021 Cash
    - 0.90 Baht 25 Feb 2021 Cash
    - 0.90 Baht 27 Nov 2020 Cash
    - 0.90 Baht 26 Aug 2020 Cash
    01 Jan 2019 - 31 Dec 2019 0.90 Baht 27 May 2020 Cash
    - 0.90 Baht 28 Feb 2020 Cash
    - 0.90 Baht 13 Dec 2019 Cash
    - 0.90 Baht 06 Sep 2019 Cash
    - 30.00 Baht 24 May 2019 Cash
    - 30.00 Baht 20 Mar 2019 Cash
     
    Auditor
    (Effective Until 31/12/2021)
    MR. PERADATE PONGSATHIANSAK/DHARMNITI AUDITING CO., LTD.
    MR. THANAWUT PIBOONSAWAT/DHARMNITI AUDITING CO., LTD.
    MISS SULALIT ARDSAWANG/DHARMNITI AUDITING CO., LTD.
    MISS SORAYA TINTASUWAN/DHARMNITI AUDITING CO., LTD.
    F/S Year ended 31/12
    Latest Type of Report Unqualified opinion with an emphasis of matters
    Financial Data
    Statement of Financial Position (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Cash And Cash Equivalents 644.44 460.06 616.02 1,012.47 889.92
    A/R Net 3,488.42 1,232.82 1,273.59 573.18 351.21
    Inventories 762.70 682.08 754.00 622.59 566.92
    Current Assets 5,885.33 3,237.27 3,351.86 2,609.04 2,181.43
    PP&E Net 9,318.84 7,660.54 8,000.00 1,783.68 2,113.67
    Non-Current Assets 28,698.62 21,780.34 23,905.49 15,856.35 13,049.90
    Total Assets 34,583.95 25,017.61 27,257.35 18,465.39 15,231.32
    OD 5,408.84 5,282.11 5,608.80 4,054.91 882.57
    A/P Net 654.19 463.40 546.99 341.69 294.34
    Current portion of LT 1,549.49 961.21 1,140.71 - 55.00
    Current Liabilities 9,979.12 7,952.68 8,402.40 4,852.97 1,820.11
    Non-Current Liabilities 3,494.09 2,288.62 2,601.85 465.93 337.85
    Total Liabilities 13,473.21 10,241.30 11,004.25 5,318.90 2,157.97
    Authorized Capital 150.00 150.00 150.00 150.00 150.00
    Paid-Up Capital 120.00 120.00 120.00 120.00 120.00
    Premium (Discount) on Share Capital - - - - -
    Retained Earnings (Deficit) 13,579.26 10,483.76 10,642.04 10,633.65 10,394.70
    Treasury Stock - - - - -
    Shares Of The Company Held By Subsidiaries - - - - -
    Other Components Of Equity 1,711.15 -42.39 1,323.01 1,865.62 1,572.95
     - Surplus (Deficits) - - 1,323.01 - -
    Shareholders' Equity 15,410.41 10,561.37 12,085.05 12,619.26 12,087.65
    Minority Interest 5,700.33 4,214.94 4,168.05 527.23 985.70
    more
    Statement of Comprehensive Income (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Revenue From Operations 9,627.59 5,655.51 7,822.16 4,562.51 4,111.23
    Other Income 61.59 88.17 110.91 117.39 38.03
    Total Revenues 9,964.50 5,992.25 8,192.40 4,952.54 4,452.36
    Costs 6,114.22 4,621.91 6,224.02 3,155.53 2,843.54
    Selling And Administrative Expenses 1,029.32 948.21 1,259.58 528.69 460.64
    Total Cost And Expenses 7,152.62 5,570.12 7,483.60 3,931.06 3,152.86
    EBITDA 4,654.03 980.87 1,544.96 1,748.26 2,872.37
    Depre. & Amor. 806.53 512.52 716.50 180.04 188.96
    EBIT 3,847.50 468.35 828.47 1,568.22 2,683.41
    Net Profit : Owners Of The Parent 2,489.43 393.20 632.06 1,440.35 1,896.23
    EPS (B.) 2.07 1.64 2.63 6.00 158.02
    more
    Statement of Cash Flow (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Operating Cash Flow 1,389.00 485.57 894.64 576.18 872.94
    Investing Cash Flow -905.08 -1,611.46 -1,870.32 -2,034.38 1,536.21
    Financing Cash Flow -455.50 573.48 579.23 1,580.75 -1,872.33
    Net Cash Flow 28.42 -552.41 -396.45 122.55 536.82
    more
    Annualized: ROE, ROA
    Ratios 9M/2021  9M/2020  2020  2019 
    Current Ratio (X) 0.59 0.41 0.40 0.54
    ROE (%) 21.01 4.18 5.12 11.66
    ROA (%) 14.12 2.43 3.62 9.31
    D/E (X) 0.64 0.69 0.68 0.40
    Total Asset Turnover (X) 0.41 0.34 0.36 0.29
    Gross Profit Margin (%) 36.49 18.28 20.43 30.84
    EBIT Margin (%) 38.61 7.82 10.11 31.67
    Net Profit Margin (%) 33.16 3.41 5.73 26.67

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 9M/2021  9M/2020  2020  2019 
    Sales Growth 70.23 70.64 71.44 10.98
    COGs Growth 32.29 100.24 97.24 10.97
    Total Revenue Growth 66.29 65.56 65.42 11.23
    Total Expense Growth 28.41 105.29 90.37 24.68
    Net Profit Growth 533.11 -70.79 -56.12 -24.04

    Annualized
    Cash Cycle 9M/2021  9M/2020  2020  2019 
    A/R Turnover (Times) 5.00 8.25 8.47 9.87
    Avg. Collection Period (Days) 73.05 44.24 43.09 36.98
    Inventory Turnover (Times) 10.68 8.25 9.04 5.31
    Avg. Inventory Period (Days) 34.17 44.25 40.36 68.80
    A/P Turnover (Times) 14.83 13.59 14.01 9.92
    Avg. Payment Period (Days) 24.61 26.86 26.06 36.79
    Cash Cycle (Days) 82.62 61.63 57.39 68.99


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    No Information Found
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name -

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
     
    Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The materials and information on this site are provided for informative and educational purpose only, and do not constitute or form a part of any advice or recommendation regarding any securities. The Stock Exchange of Thailand has no responsibility for the accuracy, suitability and completeness of any information, materials, statements, figures, reports or opinions provided, and has no responsibility for any losses and damages in any cases. In case you have any inquiries or clarification regarding this summary, please directly contact the listed company who made this summary.